510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K090940Substantially Equivalent

Spotcheck Blood Spot Control, Assayed

Astoria-Pacific, Inc., Clackamas OR / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K090940 is the FDA 510(k) clearance record for SPOTCHECK BLOOD SPOT CONTROL, ASSAYED, a class I device, cleared for Astoria-Pacific, Inc. on under FDA product code JJT (Enzyme Controls (Assayed And Unassayed)). FDA records list 9 510(k) clearances for Astoria-Pacific, Inc., from to . As of , FDA records show no recalls naming K090940.

Clearance record

Decision date
Received
(255 days to decision)
Product code
JJT Enzyme Controls (Assayed And Unassayed)
Regulation
21 CFR 862.1660
Device class
Class I
Review panel
Clinical Chemistry
Applicant
Astoria-Pacific, Inc. 15130 SE 82nd Dr., Clackamas OR
510(k) summary
Summary PDF
Third party review
No

Clearances, product code JJT

Trailing 12 months

FDA records hold no clearances under product code JJT in the trailing twelve months.

FDA records show no clearances under product code JJT in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code JJT, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260